This framework describes the building blocks and actions that ECDC will use to support and EU/EEA countries and the European Commission to achieve the Sustainable Development Goal (SDG).
This document outlines the objectives and main elements of the ECDC framework for prevention of communicable diseases and related special health issues.
Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
This is the revised version of the long-term surveillance strategy for 2014–2020. It is divided into 17 targets under six priority areas, each with strategic actions to reach them, their European added value and impact on the Member States as well as risks and their possible mitigation.
The previous version is found below.
The main focus of this strategy will be for ECDC to work together with other key stakeholders to ensure that Member States are able to develop and maintain efficient and effective national surveillance systems, despite the financial pressures that can be expected over the coming years.
This document sets out the strategic priorities for all six ECDC disease-specific programmes from 2010 to 2013 based on a short description of the epidemiological background, context in which ECDC works on that specific disease or disease group, and defined gaps that require action at the European Union (EU) level.
This long-term vision and strategy on the future surveillance of communicable diseases in the EU has been developed to help direct the decisions for the long-term development of the European surveillance system.